These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Fatal pulmonary infection due to multidrug-resistant Mycobacterium abscessus in a patient with cystic fibrosis. Sanguinetti M, Ardito F, Fiscarelli E, La Sorda M, D'Argenio P, Ricciotti G, Fadda G. J Clin Microbiol; 2001 Feb; 39(2):816-9. PubMed ID: 11158161 [Abstract] [Full Text] [Related]
7. Antimicrobial resistance in Mycobacterium abscessus complex isolated from patients with skin and soft tissue infections at a tertiary teaching hospital in Taiwan. Lee MC, Sun PL, Wu TL, Wang LH, Yang CH, Chung WH, Kuo AJ, Liu TP, Lu JJ, Chiu CH, Lai HC, Chen NY, Yang JH, Wu TS. J Antimicrob Chemother; 2017 Oct 01; 72(10):2782-2786. PubMed ID: 29091186 [Abstract] [Full Text] [Related]
8. In vivo evaluation of antibiotic activity against Mycobacterium abscessus. Lerat I, Cambau E, Roth Dit Bettoni R, Gaillard JL, Jarlier V, Truffot C, Veziris N. J Infect Dis; 2014 Mar 01; 209(6):905-12. PubMed ID: 24253289 [Abstract] [Full Text] [Related]
9. Infections caused by Mycobacterium abscessus: epidemiology, diagnostic tools and treatment. Mougari F, Guglielmetti L, Raskine L, Sermet-Gaudelus I, Veziris N, Cambau E. Expert Rev Anti Infect Ther; 2016 Dec 01; 14(12):1139-1154. PubMed ID: 27690688 [Abstract] [Full Text] [Related]
11. Failure of treatment for chronic Mycobacterium abscessus meningitis despite adequate clarithromycin levels in cerebrospinal fluid. Maniu CV, Hellinger WC, Chu SY, Palmer R, Alvarez-Elcoro S. Clin Infect Dis; 2001 Sep 01; 33(5):745-8. PubMed ID: 11486298 [Abstract] [Full Text] [Related]
12. Cutaneous infection with rapidly-growing mycobacterial infection following heart transplant: a case report and review of the literature. Freudenberger RS, Simafranca SM. Transplant Proc; 2006 Jun 01; 38(5):1526-9. PubMed ID: 16797350 [Abstract] [Full Text] [Related]
13. Erm(41)-dependent inducible resistance to azithromycin and clarithromycin in clinical isolates of Mycobacterium abscessus. Maurer FP, Castelberg C, Quiblier C, Böttger EC, Somoskövi A. J Antimicrob Chemother; 2014 Jun 01; 69(6):1559-63. PubMed ID: 24500188 [Abstract] [Full Text] [Related]
15. Clinical outcome of Mycobacterium abscessus infection and antimicrobial susceptibility testing. Huang YC, Liu MF, Shen GH, Lin CF, Kao CC, Liu PY, Shi ZY. J Microbiol Immunol Infect; 2010 Oct 01; 43(5):401-6. PubMed ID: 21075707 [Abstract] [Full Text] [Related]
16. [Susceptibility to antimicrobial agents of rapidly growing mycobacteria]. Ruiz-Aragón J, García-Agudo L, Flores S, Rodríguez MJ, Marín P, García-Martos P. Rev Esp Quimioter; 2007 Dec 01; 20(4):429-32. PubMed ID: 18563216 [Abstract] [Full Text] [Related]
19. Novel drug combination for Mycobacterium abscessus disease therapy identified in a Drosophila infection model. Oh CT, Moon C, Park OK, Kwon SH, Jang J. J Antimicrob Chemother; 2014 Jun 01; 69(6):1599-607. PubMed ID: 24519481 [Abstract] [Full Text] [Related]
20. Evaluation of antimicrobial susceptibilities of rapidly growing mycobacteria by Sensititre RAPMYCO panel. Cavusoglu C, Gurpinar T, Ecemis T. New Microbiol; 2012 Jan 01; 35(1):73-6. PubMed ID: 22378556 [Abstract] [Full Text] [Related] Page: [Next] [New Search]